Zoetis
ZTS
$0.61 (-0.35%)
1D
1W
3M
1Y
5Y
ALL
Zoetis Inc. is focused on the discovery, development, manufacture and commercialization of medicines, vaccines, diagnostic products, biodevices, genetic tests and precision livestock farming technology. The Company has a business, commercializing products across eight core species: dogs, cats and horses (collectively, companion animals) and cattle, swine, poultry, fish and sheep (collectively, livestock); and within product categories such as vaccines, anti-infectives, parasiticides, dermatology, other pharmaceutical products, medicated feed additives and animal health diagnostics. The Company's segments include the United States and International. Within each of these operating segments, it offers a product portfolio for both livestock and companion animal customers.
Open
Prior close
Today's high
Today's low
52 Week high
52 Week low
Zacks Investment Research • 2 days ago • ZTS
SDZNY vs. ZTS: Which Stock Should Value Investors Buy Now?Seeking Alpha • 2 days ago • ZTS
Zoetis: This Beautifully Boring, Slow-Growing Compounder Is A BuyAfter Earnings • 8 days ago • ZTS
Zoetis: The Major Player in the $500B Pet Market You May Not Have Heard OfThe Motley Fool • 9 days ago • ZTS
1 Magnificent S&P 500 Dividend Stock Down 12% to Buy After Its Recent PullbackBusiness Wire • 9 days ago • ZTS
Zoetis Appoints Jamie Brannan to Newly Created Chief Commercial Officer RoleCharts and pricing are provided for informational purposes only. The current market data is delayed up to 15 minutes. The accuracy of any market data displayed is not guaranteed.